Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gynecology

  Free Subscription

Articles published in
Int J Cancer
    September 2021
  1. SARINK D, White KK, Loo LWM, Wu AH, et al
    Racial/ethnic differences in postmenopausal breast cancer risk by hormone receptor status: the Multiethnic Cohort Study.
    Int J Cancer. 2021 Sep 6. doi: 10.1002/ijc.33795.
    >> Share

  2. COLE SE, John EM, Hines LM, Phipps AI, et al
    Cumulative menstrual months and breast cancer risk by hormone receptor status and ethnicity: The Breast Cancer Etiology in Minorities (BEM) Study.
    Int J Cancer. 2021 Sep 1. doi: 10.1002/ijc.33791.
    >> Share

  3. IYOSHI S, Yoshihara M, Nakamura K, Sugiyama M, et al
    Pro-tumoral behavior of omental adipocyte-derived fibroblasts in tumor microenvironment at the metastatic site of ovarian cancer.
    Int J Cancer. 2021 Sep 1. doi: 10.1002/ijc.33770.
    >> Share

    August 2021
  4. SALTA S, Maia-Moco L, Estevao-Pereira H, Sequeira JP, et al
    Performance of DNA methylation-based biomarkers in the Cervical Cancer Screening Program of Northern Portugal: a feasibility study.
    Int J Cancer. 2021 Aug 30. doi: 10.1002/ijc.33778.
    >> Share

  5. ZHENG KH, Zhu K, Wactawski-Wende J, Freudenheim JL, et al
    Caffeine Intake from Coffee and Tea and Invasive Breast Cancer Incidence among Postmenopausal Women in the Women's Health Initiative.
    Int J Cancer. 2021 Aug 21. doi: 10.1002/ijc.33771.
    >> Share

  6. WANG T, Jake-Schoffman DE, Townsend MK, Vinci C, et al
    Early life physical activity and risk of ovarian cancer in adulthood.
    Int J Cancer. 2021 Aug 16. doi: 10.1002/ijc.33760.
    >> Share

  7. ZHAO S, Chen L, Zang Y, Liu W, et al
    Endometrial cancer in lynch syndrome.
    Int J Cancer. 2021 Aug 16. doi: 10.1002/ijc.33763.
    >> Share

  8. KEANE A, Ng CW, Simms KT, Nguyen D, et al
    The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost-effectiveness of HPV screening with self-collection and digital registry support.
    Int J Cancer. 2021 Aug 7. doi: 10.1002/ijc.33759.
    >> Share

    July 2021
  9. COUGHLAN AY, Testa G
    Exploiting epigenetic dependencies in ovarian cancer therapy.
    Int J Cancer. 2021 Jul 2. doi: 10.1002/ijc.33727.
    >> Share

    June 2021
  10. VAN SCHALKWYK C, Moodley J, Welte A, Johnson LF, et al
    Modelling the impact of prevention strategies on cervical cancer incidence in South Africa.
    Int J Cancer. 2021 Jun 24. doi: 10.1002/ijc.33716.
    >> Share

  11. DARELIUS A, Kristjansdottir B, Dahm-Kahler P, Strandell A, et al
    Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation - A nationwide case control study.
    Int J Cancer. 2021 Jun 21. doi: 10.1002/ijc.33714.
    >> Share

  12. BUDUKH A, Dikshit R, Chaturvedi P
    Outcome of the randomized control screening trials on Oral, Cervix and Breast Cancer from India and way forward in COVID-19 pandemic situation.
    Int J Cancer. 2021 Jun 21. doi: 10.1002/ijc.33712.
    >> Share

  13. PAVONE R, Pacquement H, Pasquet M, Sudour-Bonnange H, et al
    Childhood ovarian non-seminomatous germ cell tumors: A Highly Curable Disease With Few Long-Term Treatment-Related Toxicities. Results of the French TGM95 study.
    Int J Cancer. 2021 Jun 19. doi: 10.1002/ijc.33710.
    >> Share

  14. JAYARAJ R, Shaw P, Kumarasamy C, Shetty SS, et al
    Comments on "Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis".
    Int J Cancer. 2021;148:2857-2858.
    >> Share

  15. MALAGON T, Volesky KD, Franco EL
    Reply to: Comments on cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis.
    Int J Cancer. 2021;148:2859-2860.
    >> Share

    May 2021
  16. DEREJE N, Addissie A, Worku A, Gebremariam A, et al
    Association between waiting time for radiotherapy initiation and disease progression among women with cervical cancer in Addis Ababa, Ethiopia.
    Int J Cancer. 2021 May 17. doi: 10.1002/ijc.33689.
    >> Share

  17. KITAZAWA S, Takaoka Y, Ueda Y, Kitazawa R, et al
    Identification of Calmodulin-Like Protein 5 (CALML5) as tumor-suppressor gene silenced during early stage of carcinogenesis in squamous cell carcinoma of uterine cervix.
    Int J Cancer. 2021 May 17. doi: 10.1002/ijc.33687.
    >> Share

  18. WANG T, Townsend MK, Eliassen AH, Terry KL, et al
    Pre- and post-diagnosis leisure time physical activity and survival following diagnosis with ovarian cancer.
    Int J Cancer. 2021 May 8. doi: 10.1002/ijc.33676.
    >> Share

    April 2021
  19. RAMACHANDRAN D, Wang Y, Schurmann P, Hulse F, et al
    Association of genomic variants at PAX8 and PBX2 with cervical cancer risk.
    Int J Cancer. 2021 Apr 27. doi: 10.1002/ijc.33614.
    >> Share

  20. GREEN LI, Mathews CS, Waller J, Kitchener H, et al
    Attendance at early recall and colposcopy in routine cervical screening with human papillomavirus testing.
    Int J Cancer. 2021;148:1850-1857.
    >> Share

  21. HOPPE-SEYLER K, Herrmann AL, Daschle A, Kuhn BJ, et al
    Effects of Metformin on the virus/host cell crosstalk in HPV-positive cancer cells.
    Int J Cancer. 2021 Apr 12. doi: 10.1002/ijc.33594.
    >> Share

  22. BORGFELDT C, Soderlund-Strand A, Darlin Flygh L, Forslund O, et al
    HPV73 in cervical cancer and distribution of HPV73 variants in cervical dysplasia.
    Int J Cancer. 2021 Apr 9. doi: 10.1002/ijc.33590.
    >> Share

  23. IVERSEN L, Fielding S, Lidegaard O, Hannaford PC, et al
    Contemporary hormonal contraception and cervical cancer in women of reproductive age.
    Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33585.
    >> Share

  24. PARRA SG, Lopez-Orellana LM, Molina Duque AR, Carns JL, et al
    Reply to: Comments on Cervical cancer prevention in El Salvador: A prospective evaluation of screening and triage strategies incorporating high-resolution microendoscopy to detect cervical precancer.
    Int J Cancer. 2021 Apr 4. doi: 10.1002/ijc.33586.
    >> Share

  25. PRETORIUS RG, Belinson JL
    COMMENTS ON: CERVICAL CANCER PREVENTION IN EL SALVADOR: A PROSPECTIVE EVALUATION OF SCREENING AND TRIAGE STRATEGIES INCORPORATING HIGH-RESOLUTION MICROENDOSCOPY TO DETECT CERVICAL PRECANCER.
    Int J Cancer. 2021 Apr 4. doi: 10.1002/ijc.33587.
    >> Share

  26. LI N, Hu Y, Zhang X, Liu Y, et al
    DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population.
    Int J Cancer. 2021;148:1768-1777.
    >> Share

  27. DIMOU NL, Papadimitriou N, Mariosa D, Johansson M, et al
    Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study.
    Int J Cancer. 2021;148:1625-1636.
    >> Share

  28. CHRISTAKOUDI S, Pagoni P, Ferrari P, Cross AJ, et al
    Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
    Int J Cancer. 2021;148:1637-1651.
    >> Share

    March 2021
  29. VINK FJ, Dick S, Heideman DAM, De Strooper LMA, et al
    Classification of high-grade CIN by p16(ink4a) , Ki-67, HPV E4 and FAM19A4/miR124-2 methylation status demonstrates considerable heterogeneity with potential consequences for management.
    Int J Cancer. 2021 Mar 17. doi: 10.1002/ijc.33566.
    >> Share

  30. WATTS EL, Perez-Cornago A, Knuppel A, Tsilidis KK, et al
    Prospective analyses of testosterone and SHBG with risk of 19 types of cancer in men and postmenopausal women in UK Biobank.
    Int J Cancer. 2021 Mar 15. doi: 10.1002/ijc.33555.
    >> Share

  31. ZHAO XL, Liu ZH, Zhao S, Hu SY, et al
    Efficacy of point-of-care thermal ablation among high-risk human papillomavirus positive women in China.
    Int J Cancer. 2021;148:1419-1427.
    >> Share

  32. CHINULA L, Topazian HM, Mapanje C, Varela A, et al
    Uptake and safety of community-based 'screen-and-treat' with thermal ablation preventive therapy for cervical cancer prevention in rural Lilongwe, Malawi.
    Int J Cancer. 2021 Mar 9. doi: 10.1002/ijc.33549.
    >> Share

  33. CROSBIE EJ, Flaum N, Harkness EF, Clayton RD, et al
    Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels.
    Int J Cancer. 2021;148:1155-1163.
    >> Share

    February 2021
  34. HALL MT, Smith MA, Simms KT, Barnabas R, et al
    Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
    Int J Cancer. 2021 Feb 26. doi: 10.1002/ijc.33533.
    >> Share

  35. YANG J, Sasamoto N, Babic A, Vitonis AF, et al
    Intrauterine device use and risk of ovarian cancer: results from the New England Case-Control study and Nurses' Health Studies.
    Int J Cancer. 2021 Feb 26. doi: 10.1002/ijc.33531.
    >> Share

  36. HORTLUND M, van Mol T, Van de Pol F, Bogers JP, et al
    Human Papillomavirus Load and Genotype Analysis Improves the Prediction of Invasive Cervical Cancer.
    Int J Cancer. 2021 Feb 14. doi: 10.1002/ijc.33519.
    >> Share

  37. DONKEN R, van Niekerk D, Hamm J, Spinelli JJ, et al
    Declining Rates of Cervical Intraepithelial Neoplasia in British Columbia, Canada: An Ecological Analysis On The Effects of The School-Based HPV Vaccination Program.
    Int J Cancer. 2021 Feb 14. doi: 10.1002/ijc.33513.
    >> Share

  38. ARTHUR RS, Dannenberg AJ, Rohan TE
    The association of prediagnostic circulating levels of cardiometabolic markers, testosterone and SHBG with risk of breast cancer among normal weight postmenopausal women in the UK Biobank.
    Int J Cancer. 2021 Feb 10. doi: 10.1002/ijc.33508.
    >> Share

  39. HUANG HJ, Tung HJ, Yang LY, Chao A, et al
    Role of human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia.
    Int J Cancer. 2021;148:665-672.
    >> Share

    January 2021
  40. BETHEA TN, Ochs-Balcom HM, Bandera EV, Beeghly-Fadiel A, et al
    First- and second-degree family history of ovarian and breast cancer in relation to risk of invasive ovarian cancer in African American and White women.
    Int J Cancer. 2021 Jan 31. doi: 10.1002/ijc.33493.
    >> Share

  41. EL-ZEIN M, Gotlieb W, Gilbert L, Hemmings R, et al
    Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    Int J Cancer. 2021;148:492-501.
    >> Share

  42. INTURRISI F, Lissenberg-Witte BI, Veldhuijzen NJ, Bogaards JA, et al
    Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen-detected cervical precancer.
    Int J Cancer. 2021;148:320-328.
    >> Share

  43. O'BRIEN KM, Tworoger SS, Harris HR, Trabert B, et al
    Genital powder use and risk of uterine cancer: A pooled analysis of prospective studies.
    Int J Cancer. 2021 Jan 12. doi: 10.1002/ijc.33470.
    >> Share

  44. WANG B, Yao J, Ma R, Liu D, et al
    The mutational landscape and prognostic indicators of pseudomyxoma peritonei originating from the ovary.
    Int J Cancer. 2021 Jan 5. doi: 10.1002/ijc.33460.
    >> Share

  45. PREOBRAZHENSKAYA EV, Shleykina AU, Gorustovich OA, Martianov AS, et al
    Frequency and molecular characteristics of PALB2-associated cancers in Russian patients.
    Int J Cancer. 2021;148:203-210.
    >> Share

  46. THUIJS NB, van Beurden M, Bruggink AH, Steenbergen RDM, et al
    Vulvar intraepithelial neoplasia: Incidence and long-term risk of vulvar squamous cell carcinoma.
    Int J Cancer. 2021;148:90-98.
    >> Share

    December 2020
  47. PARRA SG, Lopez-Orellana LM, Molina Duque AR, Carns JL, et al
    Cervical cancer prevention in El Salvador: A prospective evaluation of screening and triage strategies incorporating high-resolution microendoscopy to detect cervical precancer.
    Int J Cancer. 2020 Dec 24. doi: 10.1002/ijc.33454.
    >> Share

  48. CHOI J, Jia G, Wen W, Long J, et al
    Evaluating polygenic risk scores in assessing risk of nine solid and hematologic cancers in European descendants.
    Int J Cancer. 2020;147:3416-3423.
    >> Share

  49. LU W, He F, Lin Z, Liu S, et al
    Dysbiosis of the endometrial microbiota and its association with inflammatory cytokines in endometrial cancer.
    Int J Cancer. 2020 Dec 7. doi: 10.1002/ijc.33428.
    >> Share

    November 2020
  50. LU Z, Zhu M, Marley JL, Bi K, et al
    The combined action of Mo-MDSCs and MAIT cells promotes the progression of cervical cancer.
    Int J Cancer. 2020 Nov 27. doi: 10.1002/ijc.33411.
    >> Share

  51. AN Y, Yang Q
    Tumor-associated macrophage targeted therapeutics in ovarian cancer.
    Int J Cancer. 2020 Nov 24. doi: 10.1002/ijc.33408.
    >> Share

  52. SINGH K, Gillett S, Ireson J, Hills A, et al
    M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first line treatment of high-risk Gestational Trophoblastic Neoplasia.
    Int J Cancer. 2020 Nov 19. doi: 10.1002/ijc.33403.
    >> Share

  53. KESSOUS R, Wissing MD, Laskov I, Abitbol J, et al
    Multiple lines of chemotherapy for patients with high-grade ovarian cancer - predictors for response and effect on survival.
    Int J Cancer. 2020 Nov 16. doi: 10.1002/ijc.33395.
    >> Share

  54. ABDULRAHMAN Z, de Miranda NFCC, Hellebrekers BWJ, de Vos van Steenwijk PJ, et al
    A pre-existing coordinated inflammatory microenvironment is associated with complete response of vulvar high-grade squamous intraepithelial lesions to different forms of immunotherapy.
    Int J Cancer. 2020;147:2914-2923.
    >> Share

  55. BRAY F, Laversanne M, Weiderpass E, Arbyn M, et al
    Geographic and temporal variations in the incidence of vulvar and vaginal cancers.
    Int J Cancer. 2020;147:2764-2771.
    >> Share

  56. MALAGON T, Volesky KD, Bouten S, Laprise C, et al
    Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis.
    Int J Cancer. 2020;147:2695-2707.
    >> Share

  57. PINHEIRO M, Gage JC, Clifford GM, Demarco M, et al
    Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention.
    Int J Cancer. 2020;147:2677-2686.
    >> Share

  58. BIZZARRI N, Anchora LP, Cattani P, De Vincenzo R, et al
    Peritoneal Hpv-Dna Test In Cervical Cancer (Pioneer Study): A Proof Of Concept.
    Int J Cancer. 2020 Nov 5. doi: 10.1002/ijc.33380.
    >> Share

  59. XUE Z, Novetsky AP, Einstein MH, Marcus JZ, et al
    A demonstration of automated visual evaluation of cervical images taken with a smartphone camera.
    Int J Cancer. 2020;147:2416-2423.
    >> Share

    October 2020
  60. REINHOLDT K, Thomsen LT, Munk C, Dehlendorff C, et al
    Incidence of HPV-related anogenital precancer and cancer in women with diabetes - a nationwide registry-based cohort study.
    Int J Cancer. 2020 Oct 31. doi: 10.1002/ijc.33365.
    >> Share

  61. TIAN X, Ge D, Zhang F, Zhang B, et al
    Dynamic analysis of circulating tumor DNA to predict prognosis and monitor therapeutic response in metastatic relapsed cervical cancer.
    Int J Cancer. 2020 Oct 28. doi: 10.1002/ijc.33362.
    >> Share

  62. JORDAN SJ, Na R, Weiderpass E, Adami HO, et al
    Pregnancy Outcomes and Risk of Endometrial Cancer: A Pooled Analysis of Individual Participant Data in the Epidemiology of Endometrial Cancer Consortium.
    Int J Cancer. 2020 Oct 26. doi: 10.1002/ijc.33360.
    >> Share

  63. REZHAKE R, Chen F, Hu SY, Zhao XL, et al
    Triage options to manage high-risk human papillomavirus-positive women: A population-based cross-sectional study from rural China.
    Int J Cancer. 2020;147:2053-2064.
    >> Share

  64. YANG C, Zhang L, Love-Gregory L, Sun L, et al
    Identification of Novel ALK Rearrangements in Gynecologic Clear Cell Carcinoma.
    Int J Cancer. 2020 Oct 9. doi: 10.1002/ijc.33330.
    >> Share

  65. MAJIDI A, Na R, Jordan SJ, De Fazio A, et al
    Statin use and survival following a diagnosis of ovarian cancer: A prospective observational study.
    Int J Cancer. 2020 Oct 9. doi: 10.1002/ijc.33333.
    >> Share

  66. RAMIREZ AT, Sanchez GI, Nedjai B, Agudelo MC, et al
    Effective methylation triage of HPV positive women with abnormal cytology in a middle-income country.
    Int J Cancer. 2020 Oct 2. doi: 10.1002/ijc.33314.
    >> Share

  67. CUZICK J, Adcock R, Carozzi F, Gillio-Tos A, et al
    Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
    Int J Cancer. 2020;147:1864-1873.
    >> Share

    September 2020
  68. BONDE J, Floore A, Ejegod D, Vink FJ, et al
    Methylation markers FAM19A4 and miR124-2 as triage strategy for primary HPV screen positive women; A large European multi-center study.
    Int J Cancer. 2020 Sep 30. doi: 10.1002/ijc.33320.
    >> Share

  69. ONG JS, Derks EM, Eriksson M, An J, et al
    Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population-based cohort studies and two-sample Mendelian randomization analyses.
    Int J Cancer. 2020 Sep 25. doi: 10.1002/ijc.33308.
    >> Share

  70. STALIN J, Traboulsi W, Vivancos-Stalin L, Nollet M, et al
    Therapeutic targeting of soluble CD146/MCAM with the M2J-1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146-positive invasive tumors.
    Int J Cancer. 2020;147:1666-1679.
    >> Share

  71. APOSTOLOU P, Fostira F, Kouroussis C, Kalfakakou D, et al
    BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects.
    Int J Cancer. 2020;147:1334-1342.
    >> Share

  72. EL-ZEIN M, Cheishvili D, Gotlieb W, Gilbert L, et al
    Genome-wide DNA methylation profiling identifies two novel genes in cervical neoplasia.
    Int J Cancer. 2020;147:1264-1274.
    >> Share

    August 2020
  73. TODISCO E, Gigli F, Mantiero M, Sammassimo S, et al
    Clinical presentation, diagnosis and management of Therapy-Related Hematological Disorders in Women with Epithelial Ovarian Cancer treated with Chemotherapy and Poly-ADP-Ribose Polymerase Inhibitors (PARP-i): a single Center experience.
    Int J Cancer. 2020 Aug 28. doi: 10.1002/ijc.33269.
    >> Share

  74. LOOPIK DL, Ebisch RM, IntHout J, Melchers WJ, et al
    The relative risk of noncervical high-risk human papillomavirus-related (pre)malignancies after recurrent cervical intraepithelial neoplasia grade 3: A population-based study.
    Int J Cancer. 2020;147:897-900.
    >> Share

  75. WALPOLE E, Dunn N, Youl P, Harden H, et al
    Nonbreast cancer incidence, treatment received and outcomes: Are there differences in breast screening attendees versus nonattendees?
    Int J Cancer. 2020;147:856-865.
    >> Share

    July 2020
  76. BURGER EA, Portnoy A, Campos NG, Sy S, et al
    Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries.
    Int J Cancer. 2020 Jul 24. doi: 10.1002/ijc.33233.
    >> Share

  77. GUSTAFSON LW, Booth BB, Kahlert J, Ortoft G, et al
    Trends in hysterectomy-corrected uterine cancer mortality rates during 2002-2015: mortality of non-endometrioid cancer on the rise?
    Int J Cancer. 2020 Jul 19. doi: 10.1002/ijc.33219.
    >> Share

  78. LOUVANTO K, Eriksson T, Gray P, Apter D, et al
    Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women.
    Int J Cancer. 2020;147:440-447.
    >> Share

  79. KHO PF, Amant F, Annibali D, Ashton K, et al
    Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer.
    Int J Cancer. 2020 Jul 13. doi: 10.1002/ijc.33206.
    >> Share

  80. ARBYN M, Gultekin M, Morice P, Nieminen P, et al
    The European response to the WHO call to eliminate cervical cancer as a public health problem.
    Int J Cancer. 2020 Jul 7. doi: 10.1002/ijc.33189.
    >> Share

  81. PANOUTSOPOULOU K, Avgeris M, Magkou P, Mavridis K, et al
    miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients.
    Int J Cancer. 2020 Jul 4. doi: 10.1002/ijc.33182.
    >> Share

  82. PONTI A, Basu P, Ritchie D, Anttila A, et al
    Key issues that need to be considered while revising the current annex of the European Council Recommendation (2003) on cancer screening.
    Int J Cancer. 2020;147:9-13.
    >> Share

    June 2020
  83. TOTA JE, Isidean SD, Franco EL
    Defining benchmarks for tolerable risk thresholds in cancer screening: Impact of HPV vaccination on the future of cervical cancer screening.
    Int J Cancer. 2020 Jun 25. doi: 10.1002/ijc.33178.
    >> Share

  84. WANG T, Bradshaw PT, Moorman PG, Nyante SJ, et al
    Menopausal hormone therapy use and long-term all-cause and cause-specific mortality in the Long Island Breast Cancer Study Project.
    Int J Cancer. 2020 Jun 25. doi: 10.1002/ijc.33174.
    >> Share

  85. RAMACHANDRAN D, Schurmann P, Mao Q, Wang Y, et al
    Association of genomic variants at the Human Leukocyte Antigen locus with cervical cancer risk, HPV status, and gene expression.
    Int J Cancer. 2020 Jun 24. doi: 10.1002/ijc.33171.
    >> Share

  86. GRAY P, Kann H, Pimenoff VN, Adhikari I, et al
    Long-term follow-up of human papillomavirus (HPV) type replacement among young pregnant Finnish females before and after a community-randomised HPV vaccination trial with moderate coverage.
    Int J Cancer. 2020 Jun 23. doi: 10.1002/ijc.33169.
    >> Share

  87. HANSEN JM, Nagle CM, Ibiebele TI, Grant PT, et al
    A healthy lifestyle and survival among women with ovarian cancer.
    Int J Cancer. 2020 Jun 16. doi: 10.1002/ijc.33155.
    >> Share

  88. XIAO Q, James P, Breheny P, Jia P, et al
    Outdoor light at night and postmenopausal breast cancer risk in the NIH-AARP diet and health study.
    Int J Cancer. 2020 Jun 2. doi: 10.1002/ijc.33016.
    >> Share

  89. FARNSWORTH A, Roberts JM, Garland SM, Crescini J, et al
    Detection of high-grade cervical disease among women referred directly to colposcopy following a positive HPV screening test varies with age and cytology findings.
    Int J Cancer. 2020 Jun 2. doi: 10.1002/ijc.33128.
    >> Share

    May 2020
  90. JENKINS D, Molijn A, Kazem S, Pirog EC, et al
    Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study.
    Int J Cancer. 2020 May 31. doi: 10.1002/ijc.33124.
    >> Share

  91. SENGAYI-MUCHENGETI M, Joko-Fru WY, Miranda-Filho A, Egue M, et al
    Cervical cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index (HDI): A population-based registry study.
    Int J Cancer. 2020 May 25. doi: 10.1002/ijc.33120.
    >> Share

  92. LI Y, Hendryx MS, Xun P, He K, et al
    Physical activity and risk of bladder cancer among postmenopausal women.
    Int J Cancer. 2020 May 10. doi: 10.1002/ijc.33042.
    >> Share

  93. LI X, Ding L, Song L, Gao W, et al
    Effects of exposure to polycyclic aromatic hydrocarbons combined with high-risk human papillomavirus infection on cervical intraepithelial neoplasia: A population study in Shanxi Province, China.
    Int J Cancer. 2020;146:2406-2412.
    >> Share

    April 2020
  94. OMIYALE W, Allen NE, Sweetland S
    Body size, body composition and endometrial cancer risk among postmenopausal women in UK Biobank.
    Int J Cancer. 2020 Apr 27. doi: 10.1002/ijc.33023.
    >> Share

  95. JIANG YT, Gong TT, Zhang JY, Li XQ, et al
    Infertility and ovarian cancer risk: evidence from nine prospective cohort studies.
    Int J Cancer. 2020 Apr 14. doi: 10.1002/ijc.33012.
    >> Share

  96. TIN ST, Reeves GK, Key TJ
    Body size and composition, physical activity and sedentary time in relation to endogenous hormones in pre- and post-menopausal women: findings from the UK Biobank.
    Int J Cancer. 2020 Apr 14. doi: 10.1002/ijc.33010.
    >> Share

  97. JUNG M, Gao J, Cheung L, Bongers A, et al
    ABCC4/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancer.
    Int J Cancer. 2020 Apr 10. doi: 10.1002/ijc.33005.
    >> Share

  98. IDAHL A, Cornet CL, Maldonado SG, Waterboer T, et al
    Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort.
    Int J Cancer. 2020 Apr 3. doi: 10.1002/ijc.32999.
    >> Share

  99. YANG H, Ye S, Goswami S, Li T, et al
    Highly immunosuppressive HLADR(hi) regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma.
    Int J Cancer. 2020;146:1993-2006.
    >> Share

    March 2020
  100. GONG Y, Yang J, Wang Y, Xue L, et al
    Metabolic Factors Contribute to T-cell Inhibition in the Ovarian Cancer Ascites.
    Int J Cancer. 2020 Mar 24. doi: 10.1002/ijc.32990.
    >> Share

  101. SINGH A, Gupta S, Badarukhiya JA, Sachan M, et al
    "Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer".
    Int J Cancer. 2020 Mar 19. doi: 10.1002/ijc.32984.
    >> Share

  102. DASHTI SG, Viallon V, Simpson JA, Karahalios A, et al
    Explaining the link between adiposity and colorectal cancer risk in men and postmenopausal women in the UK Biobank: a sequential causal mediation analysis.
    Int J Cancer. 2020 Mar 17. doi: 10.1002/ijc.32980.
    >> Share

  103. ESSERS PBM, van der Heijden M, Vossen D, de Roest RH, et al
    Ovarian cancer derived copy number alterations signatures are prognostic in chemoradiotherapy treated head and neck squamous cell carcinoma.
    Int J Cancer. 2020 Mar 13. doi: 10.1002/ijc.32962.
    >> Share

  104. KATO M, Onoyama I, Yoshida S, Cui L, et al
    Dual specificity phosphatase 6 plays a critical role in the maintenance of a cancer stem-like cell phenotype in human endometrial cancer.
    Int J Cancer. 2020 Mar 11. doi: 10.1002/ijc.32965.
    >> Share

  105. PILLERON S, Cabasag CJ, Ferlay J, Bray F, et al
    Cervical cancer burden in Latin America and the Caribbean: Where are we?
    Int J Cancer. 2020 Mar 9. doi: 10.1002/ijc.32956.
    >> Share

  106. HAMMER A, Demarco M, Campos N, Befano B, et al
    Study of the Risks of CIN3+ detection following multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California.
    Int J Cancer. 2020 Mar 6. doi: 10.1002/ijc.32950.
    >> Share

    February 2020
  107. ZHONG GC, Peng Y, Wang K, Wan L, et al
    Magnesium intake and primary liver cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Int J Cancer. 2020 Feb 27. doi: 10.1002/ijc.32939.
    >> Share

  108. BENVENUTO G, Todeschini P, Paracchini L, Calura E, et al
    Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer.
    Int J Cancer. 2020 Feb 25. doi: 10.1002/ijc.32935.
    >> Share

  109. JOHN EM, Phipps AI, Hines LM, Koo J, et al
    Menstrual and reproductive characteristics and breast cancer risk by hormone receptor status and race/ethnicity: The Breast Cancer Etiology in Minorities (BEM) Study.
    Int J Cancer. 2020 Feb 16. doi: 10.1002/ijc.32923.
    >> Share

  110. KOTSOPOULOS J, Narod SA
    Prophylactic salpingectomy for the prevention of ovarian cancer; who should we target?
    Int J Cancer. 2020 Feb 9. doi: 10.1002/ijc.32916.
    >> Share

  111. VENETIANER R, Clarke MA, van der Marel J, Tota J, et al
    Identification of HPV Genotypes Causing Cervical Pre-Cancer using Tissue-Based Genotyping.
    Int J Cancer. 2020 Feb 9. doi: 10.1002/ijc.32919.
    >> Share

  112. REIJNEN C, Kusters-Vandevelde HVN, Ligtenberg MJL, Bulten J, et al
    Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.
    Int J Cancer. 2020 Feb 5. doi: 10.1002/ijc.32907.
    >> Share

  113. HECK JE, Lee PC, Wu CK, Tsai HY, et al
    Gestational risk factors and childhood cancers: a cohort study in Taiwan.
    Int J Cancer. 2020 Feb 5. doi: 10.1002/ijc.32905.
    >> Share

  114. LIPPENS L, Van Bockstal M, De Jaeghere EA, Tummers P, et al
    Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead towards personalized treatment.
    Int J Cancer. 2020 Feb 3. doi: 10.1002/ijc.32893.
    >> Share

  115. FORTNER RT, Husing A, Dossus L, Tjonneland A, et al
    Theoretical potential for endometrial cancer prevention through primary risk factor modification: Estimates from the EPIC cohort.
    Int J Cancer. 2020 Feb 3. doi: 10.1002/ijc.32901.
    >> Share

  116. MELIN J, Madanat-Harjuoja L, Hirvonen E, Seppa K, et al
    Use of fertility drugs in early-onset female cancer survivors-A Finnish register-based study on 8,929 survivors.
    Int J Cancer. 2020;146:829-838.
    >> Share

  117. CLEVELAND AA, Gargano JW, Park IU, Griffin MR, et al
    Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
    Int J Cancer. 2020;146:810-818.
    >> Share

    January 2020
  118. TRICKEY A, May MT, Gill MJ, Grabar S, et al
    Cause-specific mortality after diagnosis of cancer among HIV-positive patients: a collaborative analysis of cohort studies.
    Int J Cancer. 2020 Jan 31. doi: 10.1002/ijc.32895.
    >> Share

  119. ZHAO XL, Xu XQ, Duan XZ, Rezhake R, et al
    Comparative performance evaluation of different HPV tests and triaging strategies using self-samples and feasibility assessment of thermal ablation in 'colposcopy and treat' approach: a population-based study in rural China.
    Int J Cancer. 2020 Jan 22. doi: 10.1002/ijc.32881.
    >> Share

  120. MAYO-DE-LAS-CASAS C, Velasco A, Sanchez D, Martinez-Bueno A, et al
    Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: a proof-of-concept study.
    Int J Cancer. 2020 Jan 17. doi: 10.1002/ijc.32872.
    >> Share

  121. AMITAY EL, Carr PR, Jansen L, Alwers E, et al
    Postmenopausal hormone replacement therapy and colorectal cancer risk by molecular subtypes and pathways.
    Int J Cancer. 2020 Jan 14. doi: 10.1002/ijc.32868.
    >> Share

  122. HANNIBAL CG, Frederiksen K, Vang R, Kurman RJ, et al
    Risk of specific types of ovarian cancer after borderline ovarian tumors in Denmark: a nationwide-based study.
    Int J Cancer. 2020 Jan 12. doi: 10.1002/ijc.32864.
    >> Share

  123. CHAN K, Liu SS, Wei N, Ngu SF, et al
    Primary HPV testing with cytology versus cytology alone in cervical screening - a prospective randomized controlled trial (RCT) with two rounds of screening in a Chinese population.
    Int J Cancer. 2020 Jan 10. doi: 10.1002/ijc.32861.
    >> Share

  124. YOSHIHARA M, Kajiyama H, Yokoi A, Sugiyama M, et al
    Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.
    Int J Cancer. 2020 Jan 6. doi: 10.1002/ijc.32854.
    >> Share

    December 2019
  125. GABY S, Eva E, Andreas W, Wilhelm O, et al
    Reducing Overtreatment Associated with Overdiagnosis in Cervical Cancer Screening - A Model-based Benefit-Harm Analysis for Austria.
    Int J Cancer. 2019 Dec 24. doi: 10.1002/ijc.32849.
    >> Share

  126. KANN H, Hortlund M, Eklund C, Dillner J, et al
    Human Papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control study.
    Int J Cancer. 2019 Dec 23. doi: 10.1002/ijc.32848.
    >> Share

  127. RAMRAJ SK, Elayapillai SP, Pelikan RC, Zhao YD, et al
    Novel Ovarian Cancer Maintenance Therapy Targeted at Mortalin and Mutant p53.
    Int J Cancer. 2019 Dec 17. doi: 10.1002/ijc.32830.
    >> Share

  128. LANDY R, Sasieni PD, Mathews C, Wiggins CL, et al
    Impact of screening on cervical cancer incidence. A population-based case-control study in the United States.
    Int J Cancer. 2019 Dec 13. doi: 10.1002/ijc.32826.
    >> Share

  129. WOLF D, Fiegl H, Zeimet AG, Wieser V, et al
    High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome.
    Int J Cancer. 2019 Dec 4. doi: 10.1002/ijc.32818.
    >> Share

  130. ELFSTROM KM, Sundstrom K, Andersson S, Bzhalava Z, et al
    Increasing participation in cervical screening by targeting long-term nonattenders: Randomized health services study.
    Int J Cancer. 2019;145:3033-3039.
    >> Share

    November 2019
  131. NOH H, Charvat H, Freisling H, Olafsdottir GH, et al
    Cumulative exposure to premenopausal obesity and risk of postmenopausal cancer: A population-based study in Icelandic women.
    Int J Cancer. 2019 Nov 21. doi: 10.1002/ijc.32805.
    >> Share

  132. COSPER PF, McNair C, Gonzalez I, Wong N, et al
    Decreased Local Immune Response and Retained HPV Gene Expression during Chemoradiotherapy are Associated with Treatment Resistance and Death from Cervical Cancer.
    Int J Cancer. 2019 Nov 15. doi: 10.1002/ijc.32793.
    >> Share

  133. YANG Y, Meng YL, Duan SM, Zhan SB, et al
    REBACIN(R) as a noninvasive clinical intervention for high-risk human papillomavirus persistent infection.
    Int J Cancer. 2019;145:2712-2719.
    >> Share

  134. ORUMAA M, Leinonen MK, Campbell S, Moller B, et al
    Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016.
    Int J Cancer. 2019;145:2629-2638.
    >> Share

  135. MYERS AP, Konstantinopoulos PA, Barry WT, Luo W, et al
    Phase II, 2-Stage, 2-Arm, PIK3CA Mutation Stratified Trial of MK-2206 in Recurrent Endometrial Cancer.
    Int J Cancer. 2019 Nov 12. doi: 10.1002/ijc.32783.
    >> Share

  136. WANG T, Townsend MK, Simmons V, Terry KL, et al
    Pre- and Post- Diagnosis Smoking and Survival Following Diagnosis with Ovarian Cancer.
    Int J Cancer. 2019 Nov 6. doi: 10.1002/ijc.32773.
    >> Share

  137. SOKOLENKO AP, Bizin IV, Preobrazhenskaya EV, Gorodnova TV, et al
    Molecular Profiles of BRCA1-Associated Ovarian Cancer Treated by Platinum-Based Therapy: Analysis of Primary, Residual and Relapsed Tumours.
    Int J Cancer. 2019 Nov 6. doi: 10.1002/ijc.32776.
    >> Share

    October 2019
  138. KRATZER TB, Weinstein SJ, Albanes D, Mondul AM, et al
    Vitamin D Binding Protein and Risk of Renal Cell Carcinoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).
    Int J Cancer. 2019 Oct 29. doi: 10.1002/ijc.32758.
    >> Share

  139. SAND FL, Kjaer SK, Frederiksen K, Dehlendorff C, et al
    Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status.
    Int J Cancer. 2019 Oct 24. doi: 10.1002/ijc.32752.
    >> Share

  140. FOKOM DOMGUE J, Futuh B, Ngalla C, Kakute P, et al
    Feasibility of a Community-based Cervical Cancer Screening with 'Test and Treat' strategy using self-sample for an HPV Test: Experience from rural Cameroon, Africa.
    Int J Cancer. 2019 Oct 21. doi: 10.1002/ijc.32746.
    >> Share

  141. FELIX AS, McLaughlin EM, Caan BJ, Cohn DE, et al
    Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer study.
    Int J Cancer. 2019 Oct 16. doi: 10.1002/ijc.32740.
    >> Share

  142. LEE YJ, Kim D, Shim JE, Bae SJ, et al
    Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy.
    Int J Cancer. 2019 Oct 11. doi: 10.1002/ijc.32729.
    >> Share

  143. BRAUN JA, Herrmann AL, Blase JI, Frensemeier K, et al
    Effects of the Antifungal Agent Ciclopirox in HPV-Positive Cancer Cells: Repression of Viral E6/E7 Oncogene Expression and Induction of Senescence and Apoptosis.
    Int J Cancer. 2019 Oct 11. doi: 10.1002/ijc.32709.
    >> Share

  144. SIMIN J, Rulla MT, Callens S, Engstrand L, et al
    Menopausal hormone therapy treatment options and ovarian cancer risk: A Swedish prospective population-based matched-cohort study.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32706.
    >> Share

  145. ZORZI M, Del Mistro A, Giorgi Rossi P, Laurino L, et al
    Risk of CIN2 or more severe lesions after negative HPV-mRNA E6/E7 overexpression assay and after negative HPV-DNA test: concurrent cohorts with a 5-year follow up.
    Int J Cancer. 2019 Oct 3. doi: 10.1002/ijc.32695.
    >> Share

  146. QIU JJ, Lin XJ, Tang XY, Zheng TT, et al
    Long Noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
    Int J Cancer. 2019 Oct 2. doi: 10.1002/ijc.32692.
    >> Share

  147. CASTLE PE, Burk RD, Massad LS, Eltoum IE, et al
    Epidemiological Evidence that Common HPV Types May Be Common Because of Their Ability to Evade Immune Surveillance: Results from the Women's Interagency HIV Study.
    Int J Cancer. 2019 Oct 2. doi: 10.1002/ijc.32693.
    >> Share

    September 2019
  148. SADRI NAHAND J, Moghoofei M, Salmaninejad A, Bahmanpour Z, et al
    Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.
    Int J Cancer. 2019 Sep 30. doi: 10.1002/ijc.32688.
    >> Share

  149. REIJNEN C, van der Putten LJM, Bulten J, Snijders MPLM, et al
    Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: a prospective multicentre cohort study.
    Int J Cancer. 2019 Sep 15. doi: 10.1002/ijc.32686.
    >> Share

  150. LINK T, Passek S, Wimberger P, Frank K, et al
    Serum calretinin as an independent predictor for platinum resistance and prognosis in ovarian cancer.
    Int J Cancer. 2019 Sep 11. doi: 10.1002/ijc.32676.
    >> Share

  151. LYU T, Jiang Y, Jia N, Che X, et al
    SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters.
    Int J Cancer. 2019 Sep 10. doi: 10.1002/ijc.32673.
    >> Share

  152. STOLER MH, Baker E, Boyle S, Aslam S, et al
    Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology - retrospective insights from ATHENA.
    Int J Cancer. 2019 Sep 6. doi: 10.1002/ijc.32669.
    >> Share

  153. KONG Y, Wang Z, Huang M, Zhou Z, et al
    CUL7 promotes cancer cell survival through promoting Caspase-8 ubiquitination.
    Int J Cancer. 2019;145:1371-1381.
    >> Share

  154. YI T, Feng Y, Sundaram R, Tie Y, et al
    Antitumor efficacy of PARP inhibitors in homologous recombination deficient carcinomas.
    Int J Cancer. 2019;145:1209-1220.
    >> Share

    August 2019
  155. MANICHAIKUL A, Peres LC, Wang XQ, Barnard ME, et al
    Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.
    Int J Cancer. 2019 Aug 30. doi: 10.1002/ijc.32653.
    >> Share

  156. RICE MS, Poole EM, Willett WC, Tworoger SS, et al
    Adult Dietary Fat Intake and Ovarian Cancer Risk.
    Int J Cancer. 2019 Aug 23. doi: 10.1002/ijc.32635.
    >> Share

  157. VINK FJ, Meijer CJLM, Clifford GM, Poljak M, et al
    FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study.
    Int J Cancer. 2019 Aug 7. doi: 10.1002/ijc.32614.
    >> Share

  158. RAY-COQUARD I, Cibula D, Mirza MR, Reuss A, et al
    Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer.
    Int J Cancer. 2019 Aug 5. doi: 10.1002/ijc.32606.
    >> Share

  159. RIGHOLT CH, Bozat-Emre S, Mahmud SM
    Effectiveness of school-based and high-risk human papillomavirus vaccination programs against cervical dysplasia in Manitoba, Canada.
    Int J Cancer. 2019;145:671-677.
    >> Share

    July 2019
  160. TAWE L, MacDuffie E, Narasimhamurthy M, Wang Q, et al
    Human Papillomavirus (HPV) Genotypes in Women with Invasive Cervical Cancer with and without Human Immunodeficiency Virus (HIV) Infection in Botswana.
    Int J Cancer. 2019 Jul 20. doi: 10.1002/ijc.32581.
    >> Share

  161. RAAB M, Kobayashi NF, Becker S, Kurunci-Csacsko E, et al
    Boosting the apoptotic response of high grade serous ovarian cancers with CCNE1-amplification to paclitaxel in vitro by targeting APC/C and the pro-survival protein MCL-1.
    Int J Cancer. 2019 Jul 8. doi: 10.1002/ijc.32559.
    >> Share

  162. ZHU Q, Zhang J, Chen Y, Hu Q, et al
    Whole-Exome Sequencing Of Ovarian Cancer Families Uncovers Putative Predisposition Genes.
    Int J Cancer. 2019 Jul 2. doi: 10.1002/ijc.32545.
    >> Share

  163. BERTOLI HK, Rasmussen CL, Sand FL, Albieri V, et al
    Human papillomavirus and p16 in squamous cell carcinoma and intraepithelial neoplasia of the vagina.
    Int J Cancer. 2019;145:78-86.
    >> Share

    June 2019
  164. COLDMAN AJ, van Niekerk D, Krajden M, Smith LW, et al
    Disease Detection at the 48 Month Exit Round of the HPV FOCAL Cervical Cancer Screening Trial in Women Per-Protocol Eligible for Routine Screening.
    Int J Cancer. 2019 Jun 27. doi: 10.1002/ijc.32524.
    >> Share

  165. ROHNER E, Butikofer L, Schmidlin K, Sengayi M, et al
    Cervical cancer risk in women living with HIV across four continents: A multicohort study.
    Int J Cancer. 2019 Jun 19. doi: 10.1002/ijc.32260.
    >> Share

  166. GRUNDY A, Ho V, Abrahamowicz M, Parent ME, et al
    Lifetime recreational moderate-to-vigorous physical activity and ovarian cancer risk: a case-control study.
    Int J Cancer. 2019 Jun 14. doi: 10.1002/ijc.32513.
    >> Share

  167. COSTAS L, Frias-Gomez J, Guardiola M, Benavente Y, et al
    New perspectives on screening and early detection of endometrial cancer.
    Int J Cancer. 2019 Jun 14. doi: 10.1002/ijc.32514.
    >> Share

  168. DASHTI SG, Simpson JA, Karahalios A, Viallon V, et al
    Adiposity and estrogen receptor-positive, postmenopausal breast cancer risk: quantification of the mediating effects of fasting insulin and free estradiol.
    Int J Cancer. 2019 Jun 12. doi: 10.1002/ijc.32504.
    >> Share

  169. ZENG X, Baba T, Hamanishi J, Matsumura N, et al
    Phosphorylation of STAT1 serine 727 enhances platinum resistance in uterine serous carcinoma.
    Int J Cancer. 2019 Jun 10. doi: 10.1002/ijc.32501.
    >> Share

  170. TRABERT B, Troisi R, Grotmol T, Ekbom A, et al
    Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer: a Nordic population-based case-control study.
    Int J Cancer. 2019 Jun 7. doi: 10.1002/ijc.32494.
    >> Share

  171. MPUNGA T, Umulisa MC, Tenet V, Rugwizangoga B, et al
    Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status.
    Int J Cancer. 2019 Jun 7. doi: 10.1002/ijc.32491.
    >> Share

  172. WOESTENBERG PJ, Bogaards JA, King AJ, Leussink S, et al
    Assessment of herd effects among women and heterosexual men after girls-only HPV16/18 vaccination in the Netherlands: A repeated cross-sectional study.
    Int J Cancer. 2019;144:2718-2727.
    >> Share

    May 2019
  173. MORI N, Sawada N, Iwasaki M, Yamaji T, et al
    Circulating sex hormone levels and colorectal cancer risk in Japanese postmenopausal women: The JPHC nested case-control study.
    Int J Cancer. 2019 May 27. doi: 10.1002/ijc.32431.
    >> Share

  174. WANG J, Elfstrom KM, Andrae B, Nordqvist Kleppe S, et al
    Cervical cancer case-control audit: Results from routine evaluation of a nationwide cervical screening programme.
    Int J Cancer. 2019 May 20. doi: 10.1002/ijc.32416.
    >> Share

  175. TIAN W, Bi R, Ren Y, He H, et al
    Screening for hereditary cancers in patients with endometrial cancer reveals a high frequency of germline mutations in cancer predisposition genes.
    Int J Cancer. 2019 May 4. doi: 10.1002/ijc.32389.
    >> Share

  176. KLEIBLOVA P, Stolarova L, Krizova K, Lhota F, et al
    Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer.
    Int J Cancer. 2019 May 3. doi: 10.1002/ijc.32385.
    >> Share

  177. BAO C, Yang R, Pedersen NL, Xu W, et al
    Overweight in midlife and risk of cancer in late life: A nationwide Swedish twin study.
    Int J Cancer. 2019;144:2128-2134.
    >> Share

    April 2019
  178. ASSI N, Rinaldi S, Viallon V, Dashti SG, et al
    Mediation analysis of the alcohol-postmenopausal breast cancer relationship by sex hormones in the EPIC Cohort.
    Int J Cancer. 2019 Apr 10. doi: 10.1002/ijc.32324.
    >> Share

  179. CABASAG CJ, Arnold M, Butler J, Inoue M, et al
    The influence of birth cohort and calendar period on global trends in ovarian cancer incidence.
    Int J Cancer. 2019 Apr 10. doi: 10.1002/ijc.32322.
    >> Share

  180. AMARO-FILHO SM, Gradissimo A, Usyk M, Moreira FCB, et al
    HPV73 a non-vaccine type causes cervical cancer.
    Int J Cancer. 2019 Apr 9. doi: 10.1002/ijc.32315.
    >> Share

    March 2019
  181. NURMI A, Muranen TA, Pelttari LM, Kiiski JI, et al
    Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients.
    Int J Cancer. 2019 Mar 30. doi: 10.1002/ijc.32309.
    >> Share

  182. TIAN J, Geng Y, Lv D, Li P, et al
    Using plasma cell free DNA to monitor the chemo-radiotherapy course of cervical cancer.
    Int J Cancer. 2019 Mar 28. doi: 10.1002/ijc.32295.
    >> Share

  183. LI H, Zhang W, Niu C, Lin C, et al
    Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
    Int J Cancer. 2019 Mar 20. doi: 10.1002/ijc.32293.
    >> Share

  184. BALLABIO S, Craparotta I, Paracchini L, Mannarino L, et al
    Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number variation in 3p26.2 and 8q24.3.
    Int J Cancer. 2019 Mar 20. doi: 10.1002/ijc.32288.
    >> Share

  185. BONDE J, Bottari F, Parvu V, Pedersen H, et al
    BAYESIAN ANALYSIS OF BASELINE RISK OF CIN2 AND >/=CIN3 BY HPV GENOTYPE IN A EUROPEAN REFERRAL COHORT.
    Int J Cancer. 2019 Mar 20. doi: 10.1002/ijc.32291.
    >> Share

  186. LANDY R, Schiffman M, Sasieni PD, Cheung LC, et al
    Absolute risks of cervical precancer among women who fulfil exiting guidelines based on HPV and cytology cotesting.
    Int J Cancer. 2019 Mar 12. doi: 10.1002/ijc.32268.
    >> Share

    February 2019

  187. Expression of Concern: "Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells" by Hua Yang, Lili He, Patricia Kruk, Santo V. Nicosia and Jin Q. Cheng.
    Int J Cancer. 2019 Feb 27. doi: 10.1002/ijc.32225.
    >> Share

  188. HE Y, Gu Z, Zhu Q, Chen M, et al
    CA125 over-release behavior following a 75-gram oral glucose test as a predictive biomarker of multidrug resistance in patients with ovarian cancer.
    Int J Cancer. 2019 Feb 26. doi: 10.1002/ijc.32237.
    >> Share

  189. ARRIAGA ME, Vajdic CM, Canfell K, MacInnis RJ, et al
    The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: a pooled cohort study.
    Int J Cancer. 2019 Feb 25. doi: 10.1002/ijc.32231.
    >> Share

  190. VAN LEEUWEN RW, Ostrbenk A, Poljak M, van der Zee AGJ, et al
    DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
    Int J Cancer. 2019;144:746-754.
    >> Share

    January 2019
  191. BHASKARAN SP, Chandratre K, Gupta H, Zhang L, et al
    Germline variation in BRCA1/2 is highly ethnic-specific: evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients.
    Int J Cancer. 2019 Jan 31. doi: 10.1002/ijc.32176.
    >> Share

  192. LI F, Li H, Zhang L, Li W, et al
    X chromosome-linked long noncoding RNA lnc-XLEC1 regulates c-Myc-dependent cell growth by collaborating with MBP-1 in endometrial cancer.
    Int J Cancer. 2019 Jan 30. doi: 10.1002/ijc.32166.
    >> Share

  193. RIOS P, Bailey HD, Poulalhon C, Valteau-Couanet D, et al
    Parental smoking, maternal alcohol consumption during pregnancy and the risk of neuroblastoma in children. A pooled analysis of the ESCALE and ESTELLE French studies.
    Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32161.
    >> Share

  194. KAWAKITA D, Lee YA, Gren LH, Buys SS, et al
    Fiber Intake and the Risk of Head and Neck Cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort.
    Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32162.
    >> Share

  195. TRABERT B, Michels KA, Anderson GL, Brinton LA, et al
    Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study.
    Int J Cancer. 2019 Jan 26. doi: 10.1002/ijc.32157.
    >> Share

  196. FERRERA A, Valladares W, Cabrera Y, de la Luz Hernandez M, et al
    Performance of an HPV 16/18 E6 oncoprotein test for detection of cervical precancer and cancer.
    Int J Cancer. 2019 Jan 26. doi: 10.1002/ijc.32156.
    >> Share

  197. CERVENKA I, Al Rahmoun M, Mahamat Saleh Y, Savoye I, et al
    Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study.
    Int J Cancer. 2019 Jan 22. doi: 10.1002/ijc.32150.
    >> Share

  198. PAN J, Kavanagh K, Cuschieri K, Pollock KG, et al
    Increased risk of HPV-associated genital cancers in men and women as a consequence of pre-invasive disease.
    Int J Cancer. 2019 Jan 16. doi: 10.1002/ijc.32126.
    >> Share

  199. BRANDAO RD, Mensaert K, Lopez-Perolio I, Tserpelis D, et al
    Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes.
    Int J Cancer. 2019 Jan 8. doi: 10.1002/ijc.32114.
    >> Share

  200. LEEMAN A, Del Pino M, Marimon L, Torne A, et al
    Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
    Int J Cancer. 2019;144:160-168.
    >> Share

    December 2018
  201. VAN HELLEMOND IEG, Vriens IJH, Peer PGM, Swinkels ACP, et al
    Efficacy of Anastrozole after Tamoxifen in Early Breast Cancer Patients with Chemotherapy-Induced Ovarian Function Failure.
    Int J Cancer. 2018 Dec 26. doi: 10.1002/ijc.32093.
    >> Share

  202. FORTNER RT, Poole EM, Wentzensen NA, Trabert B, et al
    Ovarian cancer risk factors by tumor aggressiveness: an analysis from the Ovarian Cancer Cohort Consortium.
    Int J Cancer. 2018 Dec 18. doi: 10.1002/ijc.32075.
    >> Share

  203. HAMERS FF, Assogba FAG, Rogel A
    Implementation and organization of cancer screening in France.
    Int J Cancer. 2018;143:3281.
    >> Share

  204. ANDREASSEN T, Hansen BT, Engesaeter B, Hashim D, et al
    Psychological Effect of Cervical Cancer Screening When Changing Primary Screening Method From Cytology to hrHPV testing.
    Int J Cancer. 2018 Dec 14. doi: 10.1002/ijc.32067.
    >> Share

  205. SULTANA F, Winch K, Saville M, Brotherton JM, et al
    Is the positive predictive value of high-grade cytology in predicting high-grade cervical disease falling due to HPV vaccination?
    Int J Cancer. 2018 Dec 10. doi: 10.1002/ijc.32050.
    >> Share

  206. RADER JS, Tsaih SW, Fullin D, Murray MW, et al
    Genetic variations in human papillomavirus and cervical cancer outcomes.
    Int J Cancer. 2018 Dec 4. doi: 10.1002/ijc.32038.
    >> Share

  207. HALEC G, Scott ME, Farhat S, Darragh TM, et al
    Toll-like receptors: Important immune checkpoints in the regression of cervical intra-epithelial neoplasia 2.
    Int J Cancer. 2018;143:2884-2891.
    >> Share

    November 2018
  208. KIM S, Wang M, Tyrer JP, Jensen A, et al
    A Comprehensive Gene-Environment Interaction Analysis in Ovarian Cancer using Genome-wide Significant Common Variants.
    Int J Cancer. 2018 Nov 29. doi: 10.1002/ijc.32029.
    >> Share

  209. UTADA M, Chernyavskiy P, Lee WJ, Franceschi S, et al
    Increasing risk of uterine cervical cancer among young Japanese women: Comparison of incidence trends in Japan, South Korea and Japanese-Americans between 1985 and 2012.
    Int J Cancer. 2018 Nov 25. doi: 10.1002/ijc.32014.
    >> Share

  210. POLMAN NJ, Veldhuijzen NJ, Heideman DAM, Snijders PJF, et al
    Management of HPV-Positive Women in Cervical Screening Using Results from Two Consecutive Screening Rounds.
    Int J Cancer. 2018 Nov 22. doi: 10.1002/ijc.32004.
    >> Share

  211. SCHUBERT S, van Luttikhuizen JL, Auber B, Schmidt G, et al
    The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: high frequency of FANCM pathogenic variants.
    Int J Cancer. 2018 Nov 13. doi: 10.1002/ijc.31992.
    >> Share

  212. RATAJ O, Haedicke-Jarboui J, Stubenrauch F, Iftner T, et al
    Brd4 inhibition suppresses HPV16 E6 expression and enhances chemoresponse: A potential new target in cervical cancer therapy.
    Int J Cancer. 2018 Nov 13. doi: 10.1002/ijc.31986.
    >> Share

  213. COOK DA, Krajden M, Brentnall AR, Gondara L, et al
    Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31976.
    >> Share

  214. ISIDEAN SD, Wang Y, Mayrand MH, Ratnam S, et al
    Assessing the Time Dependence of Prognostic Values of Cytology and Human Papillomavirus Testing in Cervical Cancer Screening.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31970.
    >> Share

  215. RAGLAN O, Kalliala I, Markozannes G, Cividini S, et al
    Risk Factors for Endometrial Cancer: An umbrella review of the literature.
    Int J Cancer. 2018 Nov 2. doi: 10.1002/ijc.31961.
    >> Share

  216. PIMENOFF VN, Tous S, Benavente Y, Alemany L, et al
    Distinct geographic clustering of oncogenic human papillomaviruses multiple infections in cervical cancers: results from a worldwide cross-sectional study.
    Int J Cancer. 2018 Nov 2. doi: 10.1002/ijc.31964.
    >> Share

    October 2018
  217. KAMINENI A, Tiro JA, Beaber EF, Silverberg MJ, et al
    Cervical Cancer Screening Research in the PROSPR I Consortium: Rationale, Methods, and Baseline Findings from a U.S. Cohort.
    Int J Cancer. 2018 Oct 24. doi: 10.1002/ijc.31940.
    >> Share

  218. MACKINTOSH ML, Derbyshire AE, McVey RJ, Bolton J, et al
    The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk.
    Int J Cancer. 2018 Oct 5. doi: 10.1002/ijc.31913.
    >> Share

    September 2018
  219. ELANDS RJ, Offermans NS, Simons CC, Schouten LJ, et al
    Associations of adult-attained height and early life energy restriction with postmenopausal breast cancer risk according to estrogen and progesterone receptor status.
    Int J Cancer. 2018 Sep 25. doi: 10.1002/ijc.31890.
    >> Share

  220. SAND FL, Munk C, Frederiksen K, Junge J, et al
    Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV types.
    Int J Cancer. 2018 Sep 24. doi: 10.1002/ijc.31883.
    >> Share

  221. LIU Z, Zhang S, Hou F, Zhang C, et al
    Inhibition of Ca(2+) -activated chloride channel ANO1 suppresses ovarian cancer through inactivating PI3K/Akt signaling.
    Int J Cancer. 2018 Sep 22. doi: 10.1002/ijc.31887.
    >> Share

  222. TSANG SH, Peisch SF, Rowan B, Markt SC, et al
    Association between Trichomonas vaginalis and prostate cancer mortality.
    Int J Cancer. 2018 Sep 22. doi: 10.1002/ijc.31885.
    >> Share

  223. WANG Q, Song R, Zhao C, Liu H, et al
    HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
    Int J Cancer. 2018 Sep 19. doi: 10.1002/ijc.31876.
    >> Share

  224. MONDAL S, Roy D, Sarkar Bhattacharya S, Jin L, et al
    Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers.
    Int J Cancer. 2018 Sep 18. doi: 10.1002/ijc.31868.
    >> Share

  225. KOMEMI O, Epstein Shochet G, Pomeranz M, Fishman A, et al
    Placenta-conditioned extracellular matrix (ECM) activates breast cancer cell survival mechanisms: A key for future distant metastases.
    Int J Cancer. 2018 Sep 8. doi: 10.1002/ijc.31861.
    >> Share

  226. SNOEK BC, Verlaat W, Babion I, Novianti PW, et al
    Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer.
    Int J Cancer. 2018 Sep 7. doi: 10.1002/ijc.31855.
    >> Share

  227. FALK RT, Manson JE, Barnabei VM, Anderson GL, et al
    Estrogen metabolism in menopausal hormone users in the Women's Health Initiative Observational Study: Does it differ between estrogen plus progestin and estrogen alone?
    Int J Cancer. 2018 Sep 5. doi: 10.1002/ijc.31851.
    >> Share

  228. LI J, Wen WX, Eklund M, Kvist A, et al
    Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.
    Int J Cancer. 2018 Sep 2. doi: 10.1002/ijc.31841.
    >> Share

  229. BAUSSANO I, Lazzarato F, Ronco G, Franceschi S, et al
    Impacts of human papillomavirus vaccination for different populations: A modeling study.
    Int J Cancer. 2018;143:1086-1092.
    >> Share

    August 2018
  230. ZHANG C, Wang X, Anaya Y, Parodi L, et al
    Distinct Molecular Pathways in Ovarian Endometrioid Adenocarcinoma with Concurrent Endometriosis.
    Int J Cancer. 2018 Aug 28. doi: 10.1002/ijc.31768.
    >> Share

  231. OSTERMAN AL, Winer RL, Gottlieb GS, Sy MP, et al
    Female genital mutilation and non-invasive cervical abnormalities and invasive cervical cancer in Senegal, West Africa: A retrospective study.
    Int J Cancer. 2018 Aug 24. doi: 10.1002/ijc.31829.
    >> Share

  232. JOSHI S, Muwonge R, Kulkarni V, Deodhar K, et al
    Incidence of cervical intraepithelial neoplasia in women infected with human immunodeficiency virus (HIV) with no evidence of disease at baseline: results of a prospective cohort study with up to 6.4 years of follow-up from India.
    Int J Cancer. 2018 Aug 22. doi: 10.1002/ijc.31826.
    >> Share

  233. CAMPOS NG, Tsu V, Jeronimo J, Regan C, et al
    Health impact of delayed implementation of cervical cancer screening programs in India: A modelling analysis.
    Int J Cancer. 2018 Aug 21. doi: 10.1002/ijc.31823.
    >> Share

  234. JIN C, Liu Z, Li Y, Bu H, et al
    PCNA-associated factor P15(PAF) , targeted by FOXM1, predicts poor prognosis in high-grade serous ovarian cancer patients.
    Int J Cancer. 2018 Aug 21. doi: 10.1002/ijc.31800.
    >> Share

  235. BUCCHI L, Baldacchini F, Mancini S, Ravaioli A, et al
    Estimating the impact of an organised screening programme on cervical cancer incidence: a 26-year study from northern Italy.
    Int J Cancer. 2018 Aug 18. doi: 10.1002/ijc.31806.
    >> Share

  236. LU X, Li Y, Xia B, Bai Y, et al
    Selection of small plasma peptides for the auxiliary diagnosis and prognosis of epithelial ovarian cancer by using UPLC/MS-based non-targeted and targeted analyses.
    Int J Cancer. 2018 Aug 16. doi: 10.1002/ijc.31807.
    >> Share

  237. KIVES Z, Juhasz K, Csakvari T, Agoston I, et al
    Cancer screening policy in Hungary.
    Int J Cancer. 2018;143:1003-1004.
    >> Share

  238. NEFF R, Rush CM, Smith B, Backes FJ, et al
    Functional characterization of recurrent FOXA2 mutations seen in endometrial cancers.
    Int J Cancer. 2018 Aug 9. doi: 10.1002/ijc.31784.
    >> Share

  239. HE W, Hou M, Zhang H, Zeng C, et al
    Clinical significance of circulating tumor cells in predicting disease progression and chemotherapy resistance in patients with gestational choriocarcinoma.
    Int J Cancer. 2018 Aug 2. doi: 10.1002/ijc.31742.
    >> Share

  240. CHUANG SC, Lin CH, Lu YS, Hsiung CA, et al
    Association of pregnancy and mortality in women diagnosed with breast cancer: A nationwide population based study in Taiwan.
    Int J Cancer. 2018 Aug 2. doi: 10.1002/ijc.31777.
    >> Share

  241. GOMIH A, Smith JS, North KE, Hudgens MG, et al
    DNA methylation of imprinted gene control regions in the regression of low-grade cervical lesions.
    Int J Cancer. 2018;143:552-560.
    >> Share

    July 2018
  242. CHEN HJ, Huang RL, Liew PL, Su PH, et al
    GATA3 as a master regulator and therapeutic target in ovarian high-grade serous carcinoma stem cells.
    Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31750.
    >> Share

  243. AKINWUNMI B, Vitonis AF, Titus L, Terry KL, et al
    Statin Therapy and Association with Ovarian Cancer risk in the New England Case Control (NEC) Study.
    Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31758.
    >> Share

  244. TESCH H, Stoetzer O, Decker T, Kurbacher CM, et al
    Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial
    Int J Cancer. 2018 Jul 11. doi: 10.1002/ijc.31738.
    >> Share

  245. CLENDENEN TV, Dorgan J, Zeleniuch-Jacquotte A
    Reply to: Anti-Mullerian hormone and breast cancer risk- is the correlation possibly associated with the PCOS?
    Int J Cancer. 2018 Jul 11. doi: 10.1002/ijc.31728.
    >> Share

  246. BLUMENFELD Z
    Anti-Mullerian hormone and breast cancer risk- is the correlation possibly associated with the PCOS?
    Int J Cancer. 2018 Jul 10. doi: 10.1002/ijc.31732.
    >> Share

  247. SAAVALAINEN L, Lassus H, But A, Tiitinen A, et al
    A nationwide cohort study on the risk of non-gynaecological cancers in women with surgically verified endometriosis.
    Int J Cancer. 2018 Jul 7. doi: 10.1002/ijc.31721.
    >> Share

  248. AUSTRIA T, Marion C, Yu V, Widschwendter M, et al
    Mechanism of cytokinesis failure in ovarian cystadenomas with defective brca1 and p53 pathways.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31659.
    >> Share

  249. CERVENKA I, Mahamat-Saleh Y, Savoye I, Dartois L, et al
    Oral contraceptive use and cutaneous melanoma risk: A french prospective cohort study.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31644.
    >> Share

  250. JASKULSKI S, Jung AY, Behrens S, Johnson T, et al
    Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: Assessment of mediation by inflammatory markers.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31647.
    >> Share

    June 2018
  251. GUSTAVSSON I, Aarnio R, Berggrund M, Hedlund-Lindberg J, et al
    Randomized study of HPV prevalence and detection of CIN2+ in vaginal self-sampling compared to cervical specimens collected by medical personnel.
    Int J Cancer. 2018 Jun 26. doi: 10.1002/ijc.31637.
    >> Share

  252. REZHAKE R, Hu SY, Zhao S, Xu XQ, et al
    Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
    Int J Cancer. 2018 Jun 26. doi: 10.1002/ijc.31633.
    >> Share

  253. DYG SPERLING C, Verdoodt F, Kjaer Hansen M, Dehlendorff C, et al
    Statin use and mortality among endometrial cancer patients: a Danish nationwide cohort study.
    Int J Cancer. 2018 Jun 19. doi: 10.1002/ijc.31625.
    >> Share

  254. KO KP, Kim SJ, Huzarski T, Gronwald J, et al
    The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers.
    Int J Cancer. 2018;142:2263-2272.
    >> Share

    May 2018
  255. OLORUNFEMI G, Ndlovu N, Masukume G, Chikandiwa A, et al
    Temporal trends in the epidemiology of cervical cancer in South Africa (1994-2012).
    Int J Cancer. 2018 May 22. doi: 10.1002/ijc.31610.
    >> Share

  256. TROISI R, Gulbech Ording A, Grotmol T, Glimelius I, et al
    Pregnancy Complications and Subsequent Breast Cancer Risk in the Mother: A Nordic population-based case-control study.
    Int J Cancer. 2018 May 11. doi: 10.1002/ijc.31600.
    >> Share

  257. BIZZARO F, Falcetta F, D'Agostini E, Decio A, et al
    Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumab.
    Int J Cancer. 2018 May 11. doi: 10.1002/ijc.31596.
    >> Share

  258. SKOLD C, Bjorge T, Ekbom A, Engeland A, et al
    Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women.
    Int J Cancer. 2018 May 8. doi: 10.1002/ijc.31581.
    >> Share

  259. HUANG RL, Chen HJ, Chen LY, Chao TK, et al
    Epigenetic loss of heparan sulfate 3-O-sulfation sensitizes ovarian carcinoma to oncogenic signals and predicts prognosis.
    Int J Cancer. 2018 May 7. doi: 10.1002/ijc.31580.
    >> Share

    April 2018
  260. CHAN KK, Wong OG, Wong ES, Chan KK, et al
    Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31535.
    >> Share

  261. DE STROOPER LMA, Berkhof J, Steenbergen RDM, Lissenberg-Witte BI, et al
    Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31539.
    >> Share

  262. CHAN KK, Wong OG, Wong ES, Chan KK, et al
    Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
    Int J Cancer. 2018 Apr 12. doi: 10.1002/ijc.31427.
    >> Share

  263. AGOSTINI A, Brunetti M, Davidson B, Trope CG, et al
    Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas.
    Int J Cancer. 2018 Apr 6. doi: 10.1002/ijc.31418.
    >> Share

  264. CUBURU N, Khan S, Thompson CD, Kim R, et al
    Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8(+) T cell responses against HPV16 oncoproteins.
    Int J Cancer. 2018;142:1467-1479.
    >> Share

    March 2018
  265. ANNUNZIATA C, Pezzuto F, Greggi S, Ionna F, et al
    Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.
    Int J Cancer. 2018 Mar 31. doi: 10.1002/ijc.31412.
    >> Share

  266. GUINTER MA, McLain AC, Merchant AT, Sandler DP, et al
    A dietary pattern based on estrogen metabolism is associated with breast cancer risk in a prospective cohort of postmenopausal women.
    Int J Cancer. 2018 Mar 25. doi: 10.1002/ijc.31387.
    >> Share

  267. PAPAEVANGELOU E, Almeida GS, Box C, deSouza NM, et al
    The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31392.
    >> Share

  268. KELLEN E, Benoy I, Vanden Broeck D, Martens P, et al
    A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31391.
    >> Share

  269. GUO W, Key TJ, Reeves GK
    Adiposity and breast cancer risk in postmenopausal women: Results from the UK Biobank prospective cohort.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31394.
    >> Share

  270. VINTERMYR OK, Andersland MS, Bjorge T, Skar R, et al
    Human papillomavirus type specific risk of progression and remission during long term follow-up of equivocal and low grade HPV-positive cervical smears.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31390.
    >> Share

  271. BROOKS JD, Sung JS, Pike MC, Orlow I, et al
    MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women.
    Int J Cancer. 2018 Mar 9. doi: 10.1002/ijc.31370.
    >> Share

  272. YU L, Jiang M, Qu P, Wu Z, et al
    Clinical Evaluation of Human Papillomavirus 16/18 Oncoprotein Test for Cervical Cancer Screening and HPV Positive Women Triage.
    Int J Cancer. 2018 Mar 9. doi: 10.1002/ijc.31368.
    >> Share

  273. WRIGHT LB, Schoemaker MJ, Jones ME, Ashworth A, et al
    Breast cancer risk in relation to history of preeclampsia and hyperemesis gravidarum: Prospective analysis in the Generations Study.
    Int J Cancer. 2018 Mar 8. doi: 10.1002/ijc.31364.
    >> Share

  274. LEHTINEN M, Soderlund-Strand A, Vanska S, Luostarinen T, et al
    Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I).
    Int J Cancer. 2018;142:949-958.
    >> Share

    February 2018
  275. KABAT GC, Kim MY, Stefanick M, Ho GYF, et al
    Metabolic obesity phenotypes and risk of colorectal cancer in postmenopausal women.
    Int J Cancer. 2018 Feb 27. doi: 10.1002/ijc.31345.
    >> Share

  276. KAAKS R, Fortner RT, Husing A, Barrdahl M, et al
    Tumor-associated auto-antibodies as early detection markers for ovarian cancer? A prospective evaluation.
    Int J Cancer. 2018 Feb 22. doi: 10.1002/ijc.31335.
    >> Share

  277. DEL MISTRO A, Adcock R, Carozzi F, Gillio-Tos A, et al
    HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2.
    Int J Cancer. 2018 Feb 17. doi: 10.1002/ijc.31326.
    >> Share

  278. LIEW PL, Huang RL, Weng YC, Fang CL, et al
    Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitors.
    Int J Cancer. 2018 Feb 16. doi: 10.1002/ijc.31324.
    >> Share

  279. RIETBERGEN MM, van Bokhoven AAJD, Lissenberg-Witte BI, Heideman DAM, et al
    Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31315.
    >> Share

  280. LECAVALIER-BARSOUM M, Chaudary N, Han K, Koritzinsky M, et al
    Targeting the CXCL12/CXCR4 Pathway and Myeloid Cells to Improve Radiation Treatment of Locally Advanced Cervical Cancer.
    Int J Cancer. 2018 Feb 8. doi: 10.1002/ijc.31297.
    >> Share

  281. FALCONER H, Yin L, Altman D
    Association between tubal ligation and endometrial cancer risk: A Swedish population-based cohort study.
    Int J Cancer. 2018 Feb 1. doi: 10.1002/ijc.31287.
    >> Share

    January 2018
  282. YANG X, Wang N, Chen J
    Subsequent primary malignancies after endometrial cancer diagnosed in American cancer registries.
    Int J Cancer. 2018 Jan 31. doi: 10.1002/ijc.31284.
    >> Share

  283. ZHENG J, Merchant AT, Wirth MD, Zhang J, et al
    Inflammatory potential of diet and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    Int J Cancer. 2018 Jan 22. doi: 10.1002/ijc.31271.
    >> Share

  284. LOKKEGAARD ECL, Morch LS
    Tibolone and risk of gynecological hormone sensitive cancer.
    Int J Cancer. 2018 Jan 19. doi: 10.1002/ijc.31267.
    >> Share

  285. DE KOK IMCM, Korfage IJ, van den Hout WB, Helmerhorst TJM, et al
    Quality of life assumptions determine which cervical cancer screening strategies are cost-effective.
    Int J Cancer. 2018 Jan 19. doi: 10.1002/ijc.31265.
    >> Share

  286. BUSUND M, Bugge NS, Braaten T, Waaseth M, et al
    Progestin-Only and Combined Oral Contraceptives and Receptor-Defined Premenopausal Breast Cancer Risk: The Norwegian Women and Cancer Study.
    Int J Cancer. 2018 Jan 19. doi: 10.1002/ijc.31266.
    >> Share

  287. CUSCHIERI K, Ronco G, Lorincz A, Smith L, et al
    Eurogin Roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programmes.
    Int J Cancer. 2018 Jan 17. doi: 10.1002/ijc.31261.
    >> Share

  288. BASU P, Ponti A, Anttila A, Ronco G, et al
    Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.
    Int J Cancer. 2018;142:44-56.
    >> Share

    December 2017
  289. LUOSTARINEN T, Apter D, Dillner J, Eriksson T, et al
    Vaccination protects against invasive HPV-associated cancers.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31231.
    >> Share

  290. GULTEKIN M, Zayifoglu Karaca M, Kucukyildiz I, Dundar S, et al
    Initial results of population based cervical cancer screening program using hpv testing in one million turkish women.
    Int J Cancer. 2017 Dec 13. doi: 10.1002/ijc.31212.
    >> Share

  291. KHAIRALLAH AS, Genestie C, Auguste A, Leary A, et al
    Impact of neoadjuvant chemotherapy on the immune microenvironment in advanced epithelial ovarian cancer: Prognostic and therapeutic implications.
    Int J Cancer. 2017 Dec 8. doi: 10.1002/ijc.31200.
    >> Share

  292. SAND FL, Frederiksen K, Munk C, Jensen SM, et al
    Long-Term Risk of Cervical Cancer Following Conization of Cervical Intraepithelial Neoplasia Grade 3 - A Danish Nationwide Cohort Study.
    Int J Cancer. 2017 Dec 8. doi: 10.1002/ijc.31202.
    >> Share

  293. KANG YJ, Smith M, Barlow E, Coffey K, et al
    Vulvar cancer in high-income countries: Increasing burden of disease.
    Int J Cancer. 2017;141:2174-2186.
    >> Share

  294. REIMER D, Boesch M, Wolf D, Marth C, et al
    Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response.
    Int J Cancer. 2017 Dec 1. doi: 10.1002/ijc.31186.
    >> Share

    November 2017
  295. JOHANSSON ALV, Andersson TM, Hsieh CC, Jirstrom K, et al
    Tumor characteristics and prognosis in women with pregnancy-associated breast cancer.
    Int J Cancer. 2017 Nov 23. doi: 10.1002/ijc.31174.
    >> Share

  296. FORTNER RT, Schock H, Le Cornet C, Husing A, et al
    Ovarian Cancer Early Detection by Circulating CA125 in the context of Anti-CA125 Autoantibody Levels: Results from the EPIC cohort.
    Int J Cancer. 2017 Nov 21. doi: 10.1002/ijc.31164.
    >> Share

  297. KIM J, Field A, Schultz KAP, Hill DA, et al
    The prevalence of DICER1 pathogenic variation in population databases.
    Int J Cancer. 2017;141:2030-2036.
    >> Share

  298. REGER MK, Zollinger TW, Liu Z, Jones JF, et al
    Dietary intake of isoflavones and coumestrol and the risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Int J Cancer. 2017 Nov 8. doi: 10.1002/ijc.31095.
    >> Share

  299. RASMUSSEN CL, Sand FL, Hoffmann Frederiksen M, Andersen KK, et al
    Does HPV status influence survival after vulvar cancer?
    Int J Cancer. 2017 Nov 1. doi: 10.1002/ijc.31139.
    >> Share

    October 2017
  300. CUPPENS T, Moisse M, Depreeuw J, Annibali D, et al
    Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways.
    Int J Cancer. 2017 Oct 24. doi: 10.1002/ijc.31129.
    >> Share

  301. FELIX AS, Brasky TM, Cohn DE, Mutch DG, et al
    Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.
    Int J Cancer. 2017 Oct 24. doi: 10.1002/ijc.31127.
    >> Share

  302. MATSUZAKI S, Serada S, Hiramatsu K, Nojima S, et al
    Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31124.
    >> Share

  303. LANDY R, Windridge P, Gillman MS, Sasieni PD, et al
    What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study.
    Int J Cancer. 2017 Oct 11. doi: 10.1002/ijc.31094.
    >> Share

  304. MATSUO K, Shimada M, Yamaguchi S, Kanao H, et al
    Identifying a candidate population for ovarian conservation in young women with clinical stage IB-IIB cervical cancer.
    Int J Cancer. 2017 Oct 4. doi: 10.1002/ijc.31084.
    >> Share

  305. PAN R, Zhu M, Yu C, Lv J, et al
    Cancer incidence and mortality: A cohort study in China, 2008-2013.
    Int J Cancer. 2017;141:1315-1323.
    >> Share

    September 2017
  306. VIDART D'EGURBIDE BAGAZGOITIA , Bailey HD, Orsi L, Lacour B, et al
    Maternal residential pesticide use during pregnancy and risk of malignant childhood brain tumors: A pooled analysis of the ESCALE and ESTELLE studies (SFCE).
    Int J Cancer. 2017 Sep 26. doi: 10.1002/ijc.31073.
    >> Share

  307. GAITSKELL K, Green J, Pirie K, Barnes I, et al
    Histological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective Million Women Study.
    Int J Cancer. 2017 Sep 20. doi: 10.1002/ijc.31063.
    >> Share

  308. RICE MS, Rist PM, Winter AC, Kurth T, et al
    Migraine and invasive epithelial ovarian cancer risk in the Nurses' Health Study II and the Women's Health Study.
    Int J Cancer. 2017 Sep 20. doi: 10.1002/ijc.31062.
    >> Share

  309. JUNG S, Allen N, Arslan AA, Baglietto L, et al
    Anti-Mullerian Hormone and risk of ovarian cancer in nine cohorts.
    Int J Cancer. 2017 Sep 18. doi: 10.1002/ijc.31058.
    >> Share

  310. QUIST AJL, Inoue-Choi M, Weyer PJ, Anderson KE, et al
    Ingested nitrate and nitrite, disinfection by-products, and pancreatic cancer risk in postmenopausal women.
    Int J Cancer. 2017 Sep 16. doi: 10.1002/ijc.31055.
    >> Share

  311. FABER MT, Sand FL, Albieri V, Norrild B, et al
    Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva.
    Int J Cancer. 2017;141:1161-1169.
    >> Share

  312. ZHANG Q, Dong L, Hu S, Feng R, et al
    Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China.
    Int J Cancer. 2017;141:1110-1119.
    >> Share

    August 2017
  313. RAKISLOVA N, Clavero O, Alemany L, Saco A, et al
    "Histological characteristics of HPV-associated and -independent squamous cell carcinomas of the vulva: A study of 1594 cases".
    Int J Cancer. 2017 Aug 17. doi: 10.1002/ijc.31006.
    >> Share

  314. CLARKE MA, Luhn P, Gage JC, Bodelon C, et al
    Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.
    Int J Cancer. 2017;141:701-710.
    >> Share

  315. CHASIMPHA SJD, Parkin DM, Masamba L, Dzamalala CP, et al
    Three-year cancer incidence in Blantyre, Malawi (2008-2010).
    Int J Cancer. 2017;141:694-700.
    >> Share

    July 2017
  316. KHAN S, Oosterhuis K, Wunderlich K, Bunnik EM, et al
    Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease.
    Int J Cancer. 2017;141:393-404.
    >> Share

  317. GU F, Zhang H, Hyland PL, Berndt S, et al
    Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.
    Int J Cancer. 2017 Jul 12. doi: 10.1002/ijc.30883.
    >> Share

  318. VELDHUIJZEN NJ, Polman NJ, Snijders PJF, Meijer CJLM, et al
    Stratifying HPV-positive women for CIN3+ risk after one and two rounds of HPV-based screening.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30865.
    >> Share

    June 2017
  319. MATSUMOTO K, Yaegashi N, Iwata T, Yamamoto K, et al
    Early impact of the Japanese immunization program implemented before the HPV vaccination crisis.
    Int J Cancer. 2017 Jun 28. doi: 10.1002/ijc.30855.
    >> Share

    May 2017
  320. AGORASTOS T, Chatzistamatiou K, Moysiadis T, Kaufmann AM, et al
    Human papillomavirus E7 protein detection as a method of triage to colposcopy of HPV positive women, in comparison to genotyping and cytology. Final results of the PIPAVIR study.
    Int J Cancer. 2017 May 3. doi: 10.1002/ijc.30761.
    >> Share

  321. SHEN C, Liu Y, Shi S, Zhang R, et al
    Long-distance interaction of the integrated HPV fragment with MYC gene and 8q24.22 region up-regulating the allele-specific MYC expression in HeLa cells.
    Int J Cancer. 2017 May 3. doi: 10.1002/ijc.30763.
    >> Share

    April 2017
  322. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
    Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
    >> Share

    January 2017
  323. MANCINI S, Ravaioli A, Giuliani O, Vattiato R, et al
    Incidence and survival trends of cervical adenocarcinoma in Italy: Cytology screening has become more effective in downstaging the disease but not in detecting its precursors.
    Int J Cancer. 2017;140:247-248.
    >> Share

    December 2016
  324. BOGANI G, Chiappa V, Martinelli F, Raspagliesi F, et al
    Type-Specific HPV Infection Correlates with Risk of Recurrence of Vulvar Intraepithelial Neoplasia Usual Type.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30585.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016